Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGrace Crocker2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
Pioneer Group Welcomes R&D Funding Announced In Budget For Life Sciences And Planetary HealthAmy Cotterill2024-11-14T09:17:40+00:00October 30th, 2024|News|
MediCity Nottingham: 4D Medicine Raises £3.4m For Unique Biomaterial PlatformGrace Crocker2024-11-28T14:22:54+00:00July 26th, 2024|Investment, MediCity Nottingham, News|
Pioneer Group Announces Landmark Partnership With The Crown Estate & Oxford Science EnterprisesSteve Jarvis2024-08-12T10:45:52+01:00May 22nd, 2024|Headline News, Investment, News|
University Of Oxford Spin-Out Named Winner Of ‘Golden Ticket’ Programme For Planetary Health InnovationsSteve Jarvis2024-11-28T14:23:49+00:00April 12th, 2024|Accelerator, Investment, News|
Cranfield-Colworth Innovation Challenge: A Triumph Of Innovation & SustainabilitySteve Jarvis2024-11-28T15:20:56+00:00March 22nd, 2024|Colworth Park, Investment, News|
Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
Pioneer Group Leads $2.34m Investment In Neobe Therapeutics’ Cancer Therapy InnovationSteve Jarvis2024-11-28T14:25:26+00:00February 29th, 2024|Investment, News|
Online Workshop: FinanceAmy Cotterill2024-02-28T15:48:05+00:00February 28th, 2024|External, Webinar, Workshop|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilitySteve Jarvis2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
